149 related items for PubMed ID: 9893457
1. [Standard versus long-term prednisolone with sairei-to for initial therapy in childhood steroid-responsive nephrotic syndrome: a prospective controlled study].
Yoshikawa N, Ito H, Takekoshi Y, Honda M, Awazu M, Iijima K, Nakamura H, Seino Y, Takeda N, Hattori S, Matsuda I.
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):587-90. PubMed ID: 9893457
[Abstract] [Full Text] [Related]
2. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
Kurathong P, Jesdapatarakul S.
J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
[Abstract] [Full Text] [Related]
3. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP, Thakur N, Mishra RN, Prasad R.
J Nephrol; 2012 Mar; 25(3):394-400. PubMed ID: 21928226
[Abstract] [Full Text] [Related]
4. Effects of sairei-to on the relapse of steroid-dependent nephrotic syndrome.
Kimura K, Nanba S, Tojo A, Matsuoka H, Sugimoto T.
Am J Chin Med; 1990 Mar; 18(1-2):45-50. PubMed ID: 2239814
[Abstract] [Full Text] [Related]
5. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
Abeyagunawardena AS, Trompeter RS.
Arch Dis Child; 2008 Mar; 93(3):226-8. PubMed ID: 17573408
[Abstract] [Full Text] [Related]
6. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
Bagga A, Hari P, Srivastava RN.
Pediatr Nephrol; 1999 Nov; 13(9):824-7. PubMed ID: 10603129
[Abstract] [Full Text] [Related]
7. Comparative study of prednisolone alone and prednisolone plus fusidic acid in the treatment of children with steroid-responsive nephrotic syndrome.
Cerkauskiene R, Kaltenis P.
Medicina (Kaunas); 2005 Nov; 41 Suppl 1():26-30. PubMed ID: 15901972
[Abstract] [Full Text] [Related]
8. [A prospective controlled study of sairei-to in childhood IgA nephropathy with focal/minimal mesangial proliferation. Japanese Pediatric IgA Nephropathy Treatment Study Group].
Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M.
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):503-6. PubMed ID: 9283216
[Abstract] [Full Text] [Related]
9. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF, Brodeh J.
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[Abstract] [Full Text] [Related]
10. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY, Wu CY, Tsai IJ, Tsau YK.
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[Abstract] [Full Text] [Related]
11. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
Hino S, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, Yoshioka K.
Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
[Abstract] [Full Text] [Related]
12. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D, Hari P, Sinha A, Pandey S, Bagga A.
Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976
[Abstract] [Full Text] [Related]
13. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
Kidney Int; 2015 Jan 08; 87(1):217-24. PubMed ID: 25029428
[Abstract] [Full Text] [Related]
14. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
[Abstract] [Full Text] [Related]
15. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov 10; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
16. Behavioural abnormalities in children with nephrotic syndrome.
Mishra OP, Basu B, Upadhyay SK, Prasad R, Schaefer F.
Nephrol Dial Transplant; 2010 Aug 10; 25(8):2537-41. PubMed ID: 20200003
[Abstract] [Full Text] [Related]
17. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, Miyagawa K, Okuhara K, Suehiro F, Ohshima Y, Mayumi M.
Kidney Int; 2000 Sep 10; 58(3):1247-52. PubMed ID: 10972687
[Abstract] [Full Text] [Related]
18. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD, MacLeod R, Rigby E, Clark AG.
Nephrol Dial Transplant; 2006 Jul 10; 21(7):1848-54. PubMed ID: 16311257
[Abstract] [Full Text] [Related]
19. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May 10; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
20. Clinicopathologic correlates predict the outcome in children with steroid-resistant idiopathic nephrotic syndrome treated with pulse methylprednisolone therapy.
Kirpekar R, Yorgin PD, Tune BM, Kim MK, Sibley RK.
Am J Kidney Dis; 2002 Jun 10; 39(6):1143-52. PubMed ID: 12046024
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
